Payment overview · 2025
General Payments
$137.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michele J. Kiser, MD
Allopathic & Osteopathic Physicians|Family Medicine · RENO, NV · NPI 1477527505
Verified facts
What the public records show
CMS Open Payments records show Michele J. Kiser, MD received $137.84 in general payments during 2025 across 1 reported records.
BridgeBio Pharma, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Unresolved — no canonical attribution shown | $137.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $137.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Attruby Normalized: attruby |
Drug | BridgeBio Pharma, Inc. | $137.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 713 | 204 |
| Atorvastatin Calcium | Atorvastatin Calcium | 592 | 181 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 501 | 66 |
| Amlodipine Besylate | Amlodipine Besylate | 421 | 134 |
| Omeprazole | Omeprazole | 345 | 120 |
| Losartan Potassium | Losartan Potassium | 336 | 109 |
| Gabapentin | Gabapentin | 332 | 105 |
| Lisinopril | Lisinopril | 323 | 97 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 246 | 85 |
| Alprazolam | Alprazolam | 214 | 42 |
| Metformin Hcl | Metformin Hcl | 197 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 195 | 64 |
| Zolpidem Tartrate | Zolpidem Tartrate | 192 | 30 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 191 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 175 | 43 |
| Tramadol Hcl | Tramadol Hcl | 168 | 30 |
| Pregabalin | Pregabalin | 160 | 27 |
| Trazodone Hcl | Trazodone Hcl | 159 | 48 |
| Pravastatin Sodium | Pravastatin Sodium | 157 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 156 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 152 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 137 | 43 |
| Furosemide | Furosemide | 134 | 52 |
| Glimepiride | Glimepiride | 127 | 32 |
| Diazepam | Diazepam | 125 | 33 |
| Allopurinol | Allopurinol | 123 | 42 |
| Potassium Chloride | Potassium Chloride | 122 | 40 |
| Oxycodone Hcl | Oxycodone Hcl | 119 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 39 |
| Simvastatin | Simvastatin | 115 | 36 |
| Fluoxetine Hcl | Fluoxetine Hcl | 112 | 26 |
| Spironolactone | Spironolactone | 108 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 107 | 37 |
| Sertraline Hcl | Sertraline Hcl | 105 | 31 |
| Clonazepam | Clonazepam | 100 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 29 |
| Synthroid | Levothyroxine Sodium | 93 | 22 |
| Estradiol | Estradiol | 92 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 85 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 85 | 35 |
| Prednisone | Prednisone | 85 | 29 |
| Meloxicam | Meloxicam | 84 | 27 |
| Azithromycin | Azithromycin | 77 | 53 |
| Acyclovir | Acyclovir | 76 | 38 |
| Metformin Hcl Er | Metformin Hcl | 76 | 24 |
| Eliquis | Apixaban | 75 | 18 |
| Celecoxib | Celecoxib | 73 | 27 |
| Xarelto | Rivaroxaban | 73 | 21 |
| Carvedilol | Carvedilol | 72 | 26 |
| Benazepril Hcl | Benazepril Hcl | 67 | 21 |
| Famotidine | Famotidine | 67 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | 19 |
| Irbesartan | Irbesartan | 63 | 17 |
| Promethazine Hcl | Promethazine Hcl | 63 | 15 |
| Aripiprazole | Aripiprazole | 62 | 15 |
| Ozempic | Semaglutide | 61 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 60 | 22 |
| Ezetimibe | Ezetimibe | 58 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 58 | 16 |
| Lorazepam | Lorazepam | 57 | 12 |
| Ondansetron Odt | Ondansetron | 57 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 56 | 18 |
| Ketoconazole | Ketoconazole | 56 | 26 |
| Montelukast Sodium | Montelukast Sodium | 56 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | 17 |
| Cefuroxime | Cefuroxime Axetil | 55 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 14 |
| Methocarbamol | Methocarbamol | 53 | 15 |
| Nortriptyline Hcl | Nortriptyline Hcl | 53 | 17 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 52 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 51 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 51 | 23 |
| Sumatriptan Succinate | Sumatriptan Succinate | 51 | 11 |
| Telmisartan | Telmisartan | 51 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 48 | 18 |
| Jardiance | Empagliflozin | 47 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 46 | 27 |
| Meclizine Hcl | Meclizine Hcl | 45 | 16 |
| Morphine Sulfate Er | Morphine Sulfate | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 44 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | 11 |
| Azelastine Hcl | Azelastine Hcl | 42 | 11 |
| Finasteride | Finasteride | 42 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | 12 |
| Cephalexin | Cephalexin | 39 | 29 |
| Enalapril Maleate | Enalapril Maleate | 39 | 11 |
| Baclofen | Baclofen | 38 | 11 |
| Torsemide | Torsemide | 38 | 13 |
| Alendronate Sodium | Alendronate Sodium | 37 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 36 | suppressed |
| Temazepam | Temazepam | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | 13 |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 32 | suppressed |
| Topiramate | Topiramate | 32 | suppressed |
| Valsartan | Valsartan | 32 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | 11 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 31 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Mirtazapine | Mirtazapine | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 21 |
| Fluconazole | Fluconazole | 27 | 16 |
| Propranolol Hcl | Propranolol Hcl | 27 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 26 | suppressed |
| Atenolol | Atenolol | 25 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | 12 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | 11 |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 16 |
| Mupirocin | Mupirocin | 22 | 16 |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 21 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Anastrozole | Anastrozole | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Fluocinonide | Fluocinonide | 19 | 11 |
| Trulicity | Dulaglutide | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 14 |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levoxyl | Levothyroxine Sodium | 15 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $137.84 · 1 records | BridgeBio Pharma, Inc. | Attruby | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error